Institution
Mulago Hospital
Healthcare•Kampala, Uganda•
About: Mulago Hospital is a healthcare organization based out in Kampala, Uganda. It is known for research contribution in the topics: Population & Health care. The organization has 542 authors who have published 545 publications receiving 34804 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, the authors described 28 cases of a sarcoma involving the jaws of African children and reported that it is the commonest malignant tumour of childhood seen at Mulago Hospital.
Abstract: Thirty-eight cases of a sarcoma involving the jaws of African children are described. This is a syndrome which has not previously been fully recognized. It is by far the commonest malignant tumour of childhood seen at Mulago Hospital.
1,128 citations
••
TL;DR: In this article, the authors used Cox proportional hazards regression and marginal structural modeling to assess the effect of contraceptive use on HIV-1 risk and found that women who used hormonal contraception had higher risk of acquiring HIV than those who did not.
Abstract: Summary Background Hormonal contraceptives are used widely but their effects on HIV-1 risk are unclear. We aimed to assess the association between hormonal contraceptive use and risk of HIV-1 acquisition by women and HIV-1 transmission from HIV-1-infected women to their male partners. Methods In this prospective study, we followed up 3790 heterosexual HIV-1-serodiscordant couples participating in two longitudinal studies of HIV-1 incidence in seven African countries. Among injectable and oral hormonal contraceptive users and non-users, we compared rates of HIV-1 acquisition by women and HIV-1 transmission from women to men. The primary outcome measure was HIV-1 seroconversion. We used Cox proportional hazards regression and marginal structural modelling to assess the effect of contraceptive use on HIV-1 risk. Findings Among 1314 couples in which the HIV-1-seronegative partner was female (median follow-up 18·0 [IQR 12·6–24·2] months), rates of HIV-1 acquisition were 6·61 per 100 person-years in women who used hormonal contraception and 3·78 per 100 person-years in those who did not (adjusted hazard ratio 1·98, 95% CI 1·06–3·68, p=0·03). Among 2476 couples in which the HIV-1-seronegative partner was male (median follow-up 18·7 [IQR 12·8–24·2] months), rates of HIV-1 transmission from women to men were 2·61 per 100 person-years in couples in which women used hormonal contraception and 1·51 per 100 person-years in couples in which women did not use hormonal contraception (adjusted hazard ratio 1·97, 95% CI 1·12–3·45, p=0·02). Marginal structural model analyses generated much the same results to the Cox proportional hazards regression. Interpretation Women should be counselled about potentially increased risk of HIV-1 acquisition and transmission with hormonal contraception, especially injectable methods, and about the importance of dual protection with condoms to decrease HIV-1 risk. Non-hormonal or low-dose hormonal contraceptive methods should be considered for women with or at-risk for HIV-1. Funding US National Institutes of Health and the Bill & Melinda Gates Foundation.
446 citations
••
TL;DR: Thirty‐eight cases of a sarcoma involving the jaws of African children are described, which is by far the commonest malignant tumour of childhood seen at Mulago Hospital.
Abstract: Thirty-eight cases of a sarcoma involving the jaws of African children are described. This is a syndrome which has not previously been fully recognized. It is by far the commonest malignant tumour of childhood seen at Mulago Hospital.
442 citations
••
University of Cape Town1, All India Institute of Medical Sciences2, Population Health Research Institute3, College of Health Sciences, Bahrain4, Mulago Hospital5, Boston Children's Hospital6, Jimma University7, Addis Ababa University8, Alzaiem Alazhari University9, University of Zambia10, University of Limpopo11, Banha University12, University of Malawi13, Eduardo Mondlane University14, Bayero University Kano15, University College Hospital16, University College Hospital, Ibadan17, Dr George Mukhari Hospital18, University of Abuja19
TL;DR: Rheumatic heart disease patients were young, predominantly female, and had high prevalence of major cardiovascular complications, and there is suboptimal utilization of secondary antibiotic prophylaxis, oral anti-coagulation, and contraception, and variations in the use of percutaneous and surgical interventions by country income level.
Abstract: Aims Rheumatic heart disease (RHD) accounts for over a million premature deaths annually; however, there is little contemporary information on presentation, complications, and treatment.
Methods and results This prospective registry enrolled 3343 patients (median age 28 years, 66.2% female) presenting with RHD at 25 hospitals in 12 African countries, India, and Yemen between January 2010 and November 2012. The majority (63.9%) had moderate-to-severe multivalvular disease complicated by congestive heart failure (33.4%), pulmonary hypertension (28.8%), atrial fibrillation (AF) (21.8%), stroke (7.1%), infective endocarditis (4%), and major bleeding (2.7%). One-quarter of adults and 5.3% of children had decreased left ventricular (LV) systolic function; 23% of adults and 14.1% of children had dilated LVs. Fifty-five percent ( n = 1761) of patients were on secondary antibiotic prophylaxis. Oral anti-coagulants were prescribed in 69.5% ( n = 946) of patients with mechanical valves ( n = 501), AF ( n = 397), and high-risk mitral stenosis in sinus rhythm ( n = 48). However, only 28.3% ( n = 269) had a therapeutic international normalized ratio. Among 1825 women of childbearing age (12–51 years), only 3.6% ( n = 65) were on contraception. The utilization of valvuloplasty and valve surgery was higher in upper-middle compared with lower-income countries.
Conclusion Rheumatic heart disease patients were young, predominantly female, and had high prevalence of major cardiovascular complications. There is suboptimal utilization of secondary antibiotic prophylaxis, oral anti-coagulation, and contraception, and variations in the use of percutaneous and surgical interventions by country income level.
392 citations
••
TL;DR: A patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence is described.
Abstract: Among the survivors of Ebola virus disease (EVD), complications that include uveitis can develop during convalescence, although the incidence and pathogenesis of EVD-associated uveitis are unknown We describe a patient who recovered from EVD and was subsequently found to have severe unilateral uveitis during convalescence Viable Zaire ebolavirus (EBOV) was detected in aqueous humor 14 weeks after the onset of EVD and 9 weeks after the clearance of viremia
365 citations
Authors
Showing all 545 results
Name | H-index | Papers | Citations |
---|---|---|---|
Moses R. Kamya | 60 | 435 | 12598 |
Jordan J. Feld | 57 | 277 | 13444 |
Eloi Marijon | 47 | 352 | 10005 |
Sarah G. Staedke | 47 | 169 | 6095 |
Harriet Mayanja-Kizza | 43 | 221 | 6804 |
Alphonse Okwera | 42 | 88 | 5187 |
Joo-Hyun Nam | 41 | 231 | 7216 |
James K Tumwine | 41 | 214 | 5413 |
Ian Crozier | 40 | 142 | 7922 |
Cissy Kityo | 39 | 196 | 5926 |
Philippa Musoke | 37 | 138 | 7778 |
Andrew Kambugu | 36 | 184 | 5195 |
Denis Burkitt | 35 | 73 | 8491 |
Richard Idro | 35 | 139 | 4312 |
Robert O. Opoka | 33 | 170 | 4927 |